1 |
Ali, S., Metzger, D., Bornert, J. M. and Chambon, P. 1993. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12, 1153-1160.
DOI
|
2 |
Arras, J., Thomas, K. S., Myers, P. J., Cross, A. M., Osei, A. D., Vazquez, G. E., Atkins, K. A., Conaway, M. R., Jones, M. K., Lazzara, M. J. and Bouton, A. H. 2021. Breast cancer antiestrogen resistance 3 (BCAR3) promotes tumor growth and progression in triple-negative breast cancer. Am. J. Cancer Res. 11, 4768-4787.
|
3 |
Cai, D., Iyer, A., Felekkis, K. N., Near, R. I., Luo, Z., Chernoff, J., Albanese, C., Pestell, R. G. and Lerner, A. 2003. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. Cancer Res. 63, 6802-6808.
|
4 |
Centonze, G., Natalini, D., Salemme, V., Costamagna, A., Cabodi, S. and Defilippi, P. 2021. p130Cas/BCAR1 and p140Cap/SRCIN1 adaptors: The yin yang in breast cancer? Front. Cell Dev. Biol. 9, 729093.
|
5 |
Campbell, R. A., Bhat-Nakshatri, P., Patel, N. M., Con- stantinidou, D., Ali, S. and Nakshatri, H. 2001. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 276, 9817-9824.
DOI
|
6 |
Cross, A. M., Wilson, A. L., Guerrero, M. S., Thomas, K. S., Bachir, A. I., Kubow, K. E., Horwitz, A. R. and Bouton, A. H. 2016. Breast cancer antiestrogen resistance 3-p130Cas interactions promote adhesion disassembly and invasion in breast cancer cells. Oncogene 35, 5850-5859.
DOI
|
7 |
DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding-Sauer, A., Jemal, A. and Siegel, R. L. 2019. Breast cancer statistics. CA. Cancer J. Clin. 69, 438-451.
DOI
|
8 |
Dos Santos, E. G., Dieudonne, M. N., Pecquery, R., Le Moal, V., Giudicelli, Y. and Lacasa, D. 2002. Rapid non- genomic E2 effects on p42/p44 MAPK, activator protein1, and cAMP response element binding protein in rat white adipocytes. Endocrinology 143, 930-940.
DOI
|
9 |
El-Tanani, M. K. and Green, C. D. 1997. Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol. Endocrinol. 11, 928-937.
DOI
|
10 |
Felekkis, K. N., Narsimhan, R. P., Near, R., Castro, A. F., Zheng, Y., Quilliam, L. A. and Lerner, A. 2005. AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factorlike domain-dependent manner. Mol. Cancer Res. 3, 32-41.
DOI
|
11 |
Fuentes, N. and Silveyra, P. 2019. Estrogen receptor signaling mechanisms. Adv. protein Chem. Struct. Biol. 116, 135-170.
DOI
|
12 |
Gu, Q. and Moss, R. L. 1996. 17 beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J. Neurosci. 16, 3620-3629.
DOI
|
13 |
Hanker, A. B., Sudhan, D. R. and Arteaga, C. L. 2020. Overcoming endocrine resistance in breast cancer. Cancer Cell. 37, 496-513.
DOI
|
14 |
Hsu, L. H., Chu, N. M., Lin, Y. F. and Kao, S. H. 2019. G-protein coupled estrogen receptor in breast cancer. Int. J. Mol. Sci. 20, 306.
|
15 |
Ignatov, A., Ignatov, T., Weissenborn, C., Eggemann, H., Bischoff, J., Semczuk, A., Roessner, A., Costa, S. D. and Kalinski, T. 2011. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer. Breast cancer Res. Treat. 128, 457-466.
DOI
|
16 |
Marino, M., Pallottini, V. and Trentalance, A. 1998. Estrogens cause rapid activation of IP3-PKC-alpha signal transduction pathway in HEPG2 cells. Biochem. Biophys. Res. Commun. 245, 254-258.
DOI
|
17 |
Kumar, R., Zakharov, M. N., Khan, S. H., Miki, R., Jang, H., Toraldo, G., Singh, R., Bhasin, S. and Jasuja, R. 2011. The dynamic structure of the estrogen receptor. J. Amino Acids 2011, 812540.
|
18 |
Mace, P. D., Wallez, Y., Dobaczewska, M. K., Lee, J. J., Robinson, H., Pasquale, E. B. and Riedl, S. J. 2011. NSPCas protein structures reveal a promiscuous interaction module in cell signaling. Nat. Struct. Mol. Biol. 18, 1381-1387.
DOI
|
19 |
Makkinje, A., Near, R. I., Infusini, G., Vanden Borre, P., Bloom, A., Cai, D., Costello, C. E. and Lerner, A. 2009. AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern. Cell Signal. 21, 1423-1435.
DOI
|
20 |
Marino, M., Acconcia, F. and Trentalance, A. 2003. Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol. Biol. Cell. 14, 2583-2591.
DOI
|
21 |
Martin, M. B., Franke, T. F., Stoica, G. E., Chambon, P., Katzenellenbogen, B. S., Stoica, B. A., McLemore, M. S., Olivo, S. E. and Stoica, A. 2000. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141, 4503-4511.
DOI
|
22 |
Metivier, R., Stark, A., Flouriot, G., Hubner, M. R., Brand, H., Penot, G., Manu, D., Denger, S., Reid, G., Kos, M., Russell, R. B., Kah, O., Pakdel, F. and Gannon, F. 2002. A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol. Cell. 10, 1019-1032.
DOI
|
23 |
Rigiracciolo, D. C., Santolla, M. F., Lappano, R., Vivacqua, A., Cirillo, F., Galli, G. R., Talia, M., Muglia, L., Pellegrino, M., Nohata, N., Di Martino, M. T. and Maggiolini, M. 2019. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells. J. Exp. Clin. Cancer Res. 38, 58.
|
24 |
Oh, M. J., van Agthoven, T., Choi, J. E., Jeong, Y. J., Chung, Y. H., Kim, C. M. and Jhun, B. H. 2008. BCAR3 regulates EGF-induced DNA synthesis in normal human breast MCF-12A cells. Biochem. Biophys. Res. Commun. 375, 430-434.
DOI
|
25 |
Oh, M. J., Yi, S. J., Kim, H. S., Kim, J. H., Jeong, Y. H., van Agthoven, T. and Jhun, B. H. 2013. Functional roles of BCAR3 in the signaling pathways of insulin leading to DNA synthesis, membrane ruffling and GLUT4 translocation. Biochem. Biophys. Res. Commun. 441, 911-916.
DOI
|
26 |
Oh, M. J., Kim, J. H. and Jhun, B. H. 2016. Induction of c-Jun expression by breast cancer anti-estrogen resist- ance-3 (BCAR3) in human breast MCF-12A Cells. J. Life Sci. 26, 1383-1391.
DOI
|
27 |
Rusidze, M., Adlanmerini, M., Chantalat, E., RaymondLetron, I., Cayre, S, Arnal, J. F., Deugnier, M. A. and Lenfant, F. 2021. Estrogen receptor-α signaling in post-natal mammary development and breast cancers. Cell. Mol. Life Sci. 78, 5681-5705.
DOI
|
28 |
Schlaepfer, D. D., Hauck, C. R. and Sieg, D. J. 1999. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71, 435-478.
DOI
|
29 |
Schuh, N. R., Guerrero, M. S., Schrecengost, R. S. and Bouton, A. H. 2010. BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling. J. Biol. Chem. 285, 2309-2317.
DOI
|
30 |
Seo, H. S. and Leclercq, G. 2002. Evaluation of potential implication of membrane estrogen binding sites on ERE-dependent transcriptional activity and intracellular estrogen receptor-alpha regulation in MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 80, 109-123.
DOI
|
31 |
Zimmermann, S. and Moelling, K. 1999. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744.
DOI
|
32 |
Thomas, R. S., Sarwar, N., Phoenix, F., Coombes, R. C. and Ali, S. 2008. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity. J. Mol. Endocrinol. 40, 173-184.
DOI
|
33 |
van Agthoven, T., van Agthoven, T. L., Dekker, A., van der Spek, P. J., Vreede, L. and Dorssers, L. C. 1998. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells. EMBO J. 1, 2799-2808.
|
34 |
Wallez, Y., Riedl, S. J. and Pasquale, E. B. 2014. Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance. J. Biol. Chem. 289, 10431-10444.
DOI
|